BostonPremier Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$665K Buy
2,620
+8
+0.3% +$1.86K 0.28% 29
2026
Q1
$639K Buy
2,612
+36
+1% +$8.38K 0.33% 26
2025
Q4
$533K Sell
2,576
-910
-26% -$180K 0.27% 31
2025
Q3
$646K Buy
3,486
+16
+0.5% +$2.74K 0.32% 25
2025
Q2
$530K Buy
3,470
+17
+0.5% +$2.61K 0.29% 29
2025
Q1
$573K Sell
3,453
-1,107
-24% -$173K 0.36% 24
2024
Q4
$659K Buy
+4,560
New +$707K 0.4% 24

Other funds holding JNJ

BostonPremier Wealth's JNJ Position: Q2 2026 in Review

BostonPremier Wealth increased its Johnson & Johnson (JNJ) stake by 0.31% in Q2 2026, buying an estimated $1.86K and bringing the position to 2,620 shares worth $665K. The position accounts for 0.28% of the portfolio, ranked #29.

BostonPremier Wealth first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BostonPremier Wealth held 2,620 shares of Johnson & Johnson worth $665K as of Q2 2026.
  • BostonPremier Wealth bought 8 Johnson & Johnson shares in Q2 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.28% of BostonPremier Wealth's portfolio in Q2 2026, its #29 holding.
  • BostonPremier Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BostonPremier Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.